Introduction to FDA's Psychedelic Drugs: Considerations for Clinical Investigations Guidance for Industry

PDF(930 KB)

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (8) : 969-974. DOI: 10.16153/j.1002-7777.20230875

Introduction to FDA's Psychedelic Drugs: Considerations for Clinical Investigations Guidance for Industry

Author information +

History +

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 38(8): 969-974 https://doi.org/10.16153/j.1002-7777.20230875

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

PDF(930 KB)

Accesses

Citation

Detail

Sections

Recommended